Autor: |
Xiongwei Wu, Jianyong Wang, Yuhe Duan, Yusheng Liu, Yao Liu, Xin Chen, Nan Xia, Qian Dong |
Jazyk: |
angličtina |
Rok vydání: |
2022 |
Předmět: |
|
Zdroj: |
Frontiers in Pediatrics, Vol 10 (2022) |
Druh dokumentu: |
article |
ISSN: |
2296-2360 |
DOI: |
10.3389/fped.2022.878095 |
Popis: |
ObjectiveThis study analyzed the feasibility of upfront surgical resection for pediatric PRETEXT III and IV hepatoblastoma (HB).Summary Background DataNeoadjuvant chemotherapy is recommended for patients with PRETEXT III and IV HB to obtain a chance of curative surgery. However, chemotherapy can cause toxic side effects and adverse outcomes, and the PRETEXT staging system may overstage the patients. Therefore, whether preoperative chemotherapy is necessary for HB patients remains unclear.MethodsThe clinical data of 37 children who underwent surgical resection for PRETEXT III and IV HB at our hospital were obtained retrospectively. Patients were divided into the neoadjuvant chemotherapy group (NCG; n = 19) and the routine surgery group (RSG; n = 18). Clinicopathologic characteristics, treatment regimens, and outcomes were compared between the groups.ResultsThe RSG had a lower incidence of portal vein involvement than the NCG (p |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|